Clinical trial

QUARTET-DKD: Quadruple Therapy for Type 2 Diabetic Nephropathy

NCT07775846

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2026-09-01

PhasePHASE4

Study timeline

Study start (estimated)2026-09-01Date precision: day

Registry last updated2026-08-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetic Kidney Diseaseunresolved

Interventions

empagliflozinDRUG · verified · RxNorm: empagliflozin

FinerenoneDRUG · verified · RxNorm: finerenone

Finerenone PlaceboDRUG

Mazdutide PlaceboDRUG

Angiotensin Receptor Blocker (ARB)DRUG

Sponsors & collaborators

Huijie Zhanglead sponsor

Mapped research locations

ShanghaiShanghai Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07775846 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.